Hyaluronic Acid Market to Almost Double in Size
VANCOUVER, Feb. 16 /PRNewswire/ - According to a new global report series by iData Research (www.idataresearch.net), the leading authority in medical device, dental and pharmaceutical market research, the U.S. market for orthopedic biomaterials grew by 11.5% in 2009 and is estimated to reach almost $6.3 billion by 2016. The market for orthopedic hyaluronic acid viscosupplementation (HA) in 2009 increased almost 30% over the previous year due to growth in the market for three-injection-cycle products. The report states that the launch of single-injection-products will stimulate market growth for HA therapies, while the aging population and increased incidence of osteoarthritis will drive the overall market for orthopedic biomaterials.
Orthopedic biomaterials are implanted or applied in or near bone to facilitate healing. This procedure fills in areas where bone tissue is depleted to restore structure and allow for repair, leading to bone augmentation. Some of the fastest-growing market segments include orthopedic stem cells and cartilage repair. In addition, the market for HA is estimated to see significant changes, due to the FDA approval of Genzyme Biosurgery's single-injection product, SynviscOne(R).
"The introduction of single-injection-cycle products in 2009 is attracting new patients to the viscosupplementation market and cannibalizing market shares for existing products," says Dr. Kamran Zamanian, CEO of iData. "Competition is expected to intensify, putting pressure on pricing and influencing procedural volumes."
iData's global series on the Markets for Orthopedic Biomaterials 2010 includes comprehensive analyses of the markets for:
The report series also includes comprehensive competitive analyses, which cover companies such as Biomet, DePuy, Genzyme, Medtronic, NuVasive, Sanofi Aventis, Smith & Nephew and Synthes, among others.
For more information, register free on iData's website at: http://www.idataresearch.net/idata/registration.php
Or visit us at Booth 6249 at AAOS 2010
About iData Research
iData Research (www.idataresearch.net/idata/discoveridata.php) is an international market research and consulting group focused on providing market intelligence for medical device, dental and pharmaceutical companies. iData covers research in: orthopedic biomaterials, orthopedic trauma, soft tissue, spinal implants, wound management, endoscopy, cardiovascular, dental, pharmaceuticals and more.
SOURCE iData Research Inc.
VANCOUVER, Feb. 16 /PRNewswire/ - According to a new global report series by iData Research (www.idataresearch.net), the leading authority in medical device, dental and pharmaceutical market research, the U.S. market for orthopedic biomaterials grew by 11.5% in 2009 and is estimated to reach almost $6.3 billion by 2016. The market for orthopedic hyaluronic acid viscosupplementation (HA) in 2009 increased almost 30% over the previous year due to growth in the market for three-injection-cycle products. The report states that the launch of single-injection-products will stimulate market growth for HA therapies, while the aging population and increased incidence of osteoarthritis will drive the overall market for orthopedic biomaterials.
Advertisement
Orthopedic biomaterials are implanted or applied in or near bone to facilitate healing. This procedure fills in areas where bone tissue is depleted to restore structure and allow for repair, leading to bone augmentation. Some of the fastest-growing market segments include orthopedic stem cells and cartilage repair. In addition, the market for HA is estimated to see significant changes, due to the FDA approval of Genzyme Biosurgery's single-injection product, SynviscOne(R).
Advertisement
"The introduction of single-injection-cycle products in 2009 is attracting new patients to the viscosupplementation market and cannibalizing market shares for existing products," says Dr. Kamran Zamanian, CEO of iData. "Competition is expected to intensify, putting pressure on pricing and influencing procedural volumes."
iData's global series on the Markets for Orthopedic Biomaterials 2010 includes comprehensive analyses of the markets for:
Growth Factor Therapy
Bone Graft Substitutes
Machined Bone Allografts
Hyaluronic Acid Viscosupplementation
Resorbable Tissue and Bone Fixation Devices
Tendon Allografts
Cartilage Repair
Platelet and Bone Marrow Concentration
Stem Cell Therapy
The report series also includes comprehensive competitive analyses, which cover companies such as Biomet, DePuy, Genzyme, Medtronic, NuVasive, Sanofi Aventis, Smith & Nephew and Synthes, among others.
For more information, register free on iData's website at: http://www.idataresearch.net/idata/registration.php
Or visit us at Booth 6249 at AAOS 2010
About iData Research
iData Research (www.idataresearch.net/idata/discoveridata.php) is an international market research and consulting group focused on providing market intelligence for medical device, dental and pharmaceutical companies. iData covers research in: orthopedic biomaterials, orthopedic trauma, soft tissue, spinal implants, wound management, endoscopy, cardiovascular, dental, pharmaceuticals and more.
SOURCE iData Research Inc.
